News Focus
News Focus
icon url

masterlongevity

05/15/12 11:12 PM

#142003 RE: DewDiligence #141967

this was a genentech deal, and crenezumab is still controlled by Genentech. It is in the GRED early development group, which is said to have little to no Roche influence.